Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other financing activities (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Other financing activities for 2 consecutive years, with -$8000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Other financing activities fell 100.31% to -$8000.0 in Q4 2020 year-over-year; TTM through Sep 2022 was -$8000.0, a 100.0% decrease, with the full-year FY2022 number at $150000.0, changed N/A from a year prior.
  • Other financing activities was -$8000.0 for Q4 2020 at Pliant Therapeutics, down from $3000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.6 million in Q4 2019 to a low of -$8000.0 in Q4 2020.